Skip to main content

Table 2 Clinicopathological characteristics of 548 colorectal carcinoma patients

From: Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer

Parameter

Subtype

Patients (%)

Age (years)

> 65

311 (56.8%)

≤65

237 (43.2%)

Gender

Male

292 (53.3%)

Female

256 (46.7%)

Pathologic stage

Stage I

96 (17.5%)

Stage II

210 (38.3%)

Stage III

149 (27.2%)

Stage IV

78 (14.2%)

Unknown

15 (2.7%)

Pathologic T

T1

15 (2.7%)

T2

96 (17.5%)

T3

373 (68.1%)

T4

63 (11.5%)

Tis

1 (0.2%)

Pathologic N

N0

323 (58.9%)

N1

130 (23.7%)

N2

94 (17.2%)

NX

1 (0.2%)

Pathologic M

M0

408 (74.5%)

M1

77 (14.1%)

MX

55 (10.0%)

Unknown

8 (1.5%)